A recently published study has determined that GFAP and UCH-L1 may be used as blood biomarkers to detect concussion and subconcussive injuries.
A blood test for glioblastoma may be on the horizons, as researchers identify novel biomarkers that could be used for diagnosis.
In this video, we spoke with Henrik Zetterberg to find out how challenges with replication, reproducibility and specificity could be addressed in the field.
A peek behind the paper – Sarah Hamm-Alvarez on oligomeric α-synuclein in basal tears of Parkinson’s patients
Take a look behind the scenes of a recent paper in Biomarkers in Medicine as we ask the author about oligomeric α-synuclein in basal tears of Parkinson’s patients.
Studies presented at AAIC 2019 have revealed the significant advances being made in the global search for blood-based biomarkers for dementia.
A novel study has identified the inflammatory markers IL-1 and IL-6 as potential biomarkers for diagnosis, prognosis and possible treatment targets for concussion.
A promising new study could provide an early warning system to enable people with epilepsy to know when they are at risk of having a seizure.
Researchers from the University of Oregon (OR, USA) suggest that noninvasive EEG readings could present as easily detectable biomarkers to help diagnose and improve treatment for Parkinson’s and other motor disorders.
Researchers have discovered small molecules in sebum responsible for a unique odor in people with Parkinson’s that could be used for early diagnosis.